These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 10466006)
1. [Bayesian prediction of chloramphenicol blood levels in children with sepsis and malnutrition]. Lares-Asseff I; Lugo-Goytia G; Pérez-Guillé MG; Pérez Ortíz B; Guillé-Pérez A; Juárez-Olguín H; Flores-Pérez J; Santiago P; Morlán M Rev Invest Clin; 1999; 51(3):159-65. PubMed ID: 10466006 [TBL] [Abstract][Full Text] [Related]
2. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates. McClellan SD; Farringer JA Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192 [TBL] [Abstract][Full Text] [Related]
3. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage. Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis. Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143 [TBL] [Abstract][Full Text] [Related]
5. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820 [TBL] [Abstract][Full Text] [Related]
6. [Can we use a Bayesian method to build a pharmacokinetic population in two steps?]. Cabelguenne D; Bleyzac N; Pivot C; Maire P Therapie; 2000; 55(2):277-82. PubMed ID: 10967700 [TBL] [Abstract][Full Text] [Related]
7. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation. Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm--a retrospective study. Terziivanov D; Atanasova I; Dimitrova V Int J Clin Pharmacol Ther; 1998 Jul; 36(7):376-82. PubMed ID: 9707352 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients. Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156 [TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical and biologic variables and chloramphenicol pharmacokinetic parameters in pediatric patients with sepsis. Lugo Goytia G; Lares-Asseff I; Pérez Guillé MG; Pérez AG; Mejía CL Ann Pharmacother; 2000 Mar; 34(3):393-7. PubMed ID: 10917389 [TBL] [Abstract][Full Text] [Related]
12. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods. Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method. Wang J; Liang WQ; Wu JJ; Pan CM Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy. Jiang DC; Wang L Acta Pharmacol Sin; 2004 Dec; 25(12):1576-83. PubMed ID: 15569400 [TBL] [Abstract][Full Text] [Related]
15. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H; Mayer PR; Wajdula J; Fatenejad S J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm. Debord J; Charmes JP; Marquet P; Merle L; Lachâtre G Int J Clin Pharmacol Ther; 1997 Jan; 35(1):24-7. PubMed ID: 9021438 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients. Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366 [TBL] [Abstract][Full Text] [Related]
18. [Population pharmacokinetic model for gentamycin and its predictive value]. Wang J; Liang WQ Yao Xue Xue Bao; 2001 Sep; 36(9):703-6. PubMed ID: 12580113 [TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of the Italian studies on short-term effects of air pollution]. Biggeri A; Bellini P; Terracini B; Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188 [TBL] [Abstract][Full Text] [Related]
20. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods. Huitema AD; Mathôt RA; Tibben MM; Schellens JH; Rodenhuis S; Beijnen JH Clin Pharmacol Ther; 2000 Jun; 67(6):621-30. PubMed ID: 10872644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]